CAREGEN Platform Technology
Growth FactorsTechnology
WHAT IS GROWTH FACTOR
Growth factors are proteins that bind to their own receptors on cell surface with the primary result of activating cell proliferation and/or differentiation. Not only as strong mitogens, growth factors are regulating the expressions of ECMs (Extra Cellular Matrix) like collagen, elastin, lamini and etc.
SUPERIORITY OF GROWTH FACTORS
– Competitive price based on mass production technology – High efficacy and stability by double-layered capsulation technology – High purity by sophisticated production facility and technical superiority
Biomimetic Peptides
WHAT IS BIOMIMETIC PEPTIDE
Caregen has developed biomimetic peptides since 2002 based on broad growth factor studies. Caregen’s commercialized peptides are synthetic agonists of naturally-occurring growth factors and completely mimic the action of the parental molecules. Those biomimetic peptides can provide clinical benefits similar to recombinant growth factors, reduced costs, and greater chemical stability.
COMPARATIVE ADVANTAGES OF BIOMIMETIC PEPTIDES
– Sustainable new biomimetic peptides development – Competitive price based on mass production technology – High efficacy and stability by double-layered capsulation technology – High purity by sophisticated production skill based on technical superiority
BIOMIMETIC PEPTIDES
Skin Delivery System
DOUBLE-LAYERED CAPSULATION TECHNOLOGY
Caregen’s double-layered capsulation technology improves penetration of active ingredients into skin. In addition, the molecules are protected from endogenous proteases with double- layered capsulation which gives higher efficacy.
ADVANTAGES OF DOUBLE-LAYERED CAPSULATION
– High stability by double-layered structure – High homogeneity: average diameter of particle is 140 nm and over 80% particles are below 100 nm in size. – Efficient delivery of therapeutic cosmetic components into dermal layer.
